Research-to-Practice Gaps in Multiple Sclerosis Care for Patients with Subjective Cognitive, Mental Health, and Psychosocial Concerns in a Canadian Center

Abstract

Background: People with multiple sclerosis (MS) are at increased risk for cognitive impairment, mental health concerns, and psychosocial issues, which can negatively affect disease outcomes and quality of life. Current MS care guidelines recommend integrated interdisciplinary services to address these concerns; however, issues can be overlooked during routine care. To date, there is inadequate research on how often these issues are identified and addressed during routine MS care. Methods: One hundred medical records were randomly selected and reviewed (55 relapsing-remitting MS, 17 secondary progressive MS, 8 primary progressive MS, and 20 other or subtype not indicated). All visits to, and contacts with (ie, telephone, e-mail), an MS clinic over 1 year were included in the analysis to determine the proportion of patients presenting with cognitive, mental health, and psychosocial concerns and the proportion of patients offered associated services. Results: Of the 25 patients with at least one identified concern, treatment recommendations occurred for 13 (52%). Rates of identification of cognitive, mental health, and psychosocial concerns in standard clinical practice were significantly lower than the identified prevalence in epidemiologic studies. Demographic factors had no bearing on who was offered treatment. Patients with concerns access MS clinic services more often than those without. Conclusions: Discrepancies between reported and expected frequencies may be due to overreliance on patient self-disclosure and concerns by the health care team that inadequate resources are available to address issues. An interdisciplinary team model may help address these issues.

What would improve MS clinic services for cognition? – A stakeholder panel and survey exploration

“…It has been demonstrated that rates of identification of cognitive concerns in standard clinical practice are significantly lower than the identified prevalence in epidemiologic studies. This has been attributed to overreliance on selfdisclosure by PwMS and HCP's concerns about broaching cognition when they feel that inadequate resources are available to address these issues (Walker et al, 2019).…”

Development of a behavioural intervention for cognitive fatigability in multiple sclerosis: Protocol for a pilot and feasibility study

“…We anticipate that respondents will identify several areas of unmet need, particularly as they relate to treatments for fatigue, mood, and cognitive challenges. Our own group has identified a significant gap between the research progress in these areas and the services available to address these issues in standard clinical practice ( 75 ). While exercise interventions may be more readily available in the community at large, there continue to be environmental barriers to accessibility ( 76 – 78 ).…”

A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) International Validations

“…Cognitive impairment remains a neglected and under-diagnosed symptom of MS. The “invisibility” of cognitive difficulties has meant they are often overlooked by family members, colleagues and healthcare professionals since there is no obvious external disability [ 19 ]. At routine consultation, neurologists are poor at identifying MS-related cognitive impairment [ 20 ].…”